Revenue
0 USD
2025 Q4 · USD
Annual consolidated revenue for 2025: about USD 5K, using the latest reported figures. The previous period, 2024, was about USD 2.5K.
38788 USD
19173896 shares
10.57% · 1.83 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-5.07 million USD
2025-07-01 – 2026-06-30
-4.06 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-21.
Financial data available through: 2025-03-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2,500
–
Current period
USD 5,000
–
5000 − 2500 = 2500 USD
2500 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source5000 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 298,202
–
Current period
−USD 2.9 million
–
-2901321 − -298202 = -2603119 USD
-298202 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source-2901321 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 258,928
–
Current period
−USD 1.28 million
–
-1284615 − -258928 = -1025687 USD
-258928 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source-1284615 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-04-01 – 2016-03-31 | 3181000 | Unavailable | Unavailable | Unavailable | 33000 | Unavailable | Source
|
| 2017 2016-04-01 – 2017-03-31 | 2284000 | Unavailable | Unavailable | Unavailable | -509000 | Unavailable | Source
|
| 2018 2017-04-01 – 2018-03-31 | 2918 | 2737 Derived | 181 | 202181 Derived | -202000 | Unavailable | Source
|
| 2019 2018-04-01 – 2019-03-31 | 3346 | 2595 Derived | 751 | -333249 Derived | 334000 | Unavailable | Source
|
| 2024 2023-04-01 – 2024-03-31 | 2500 | 310088 Derived | -307588 | -9386 Derived | -298202 | Unavailable | Source
|
| 2025 2024-04-01 – 2025-03-31 | 5000 | 2924365 Derived | -2919365 | -18044 Derived | -2901321 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 3181000 |
|
| 2016 | Revenue | 3181000 |
|
| 2017 | Revenue | 2284000 |
|
| 2018 | Revenue | 2918 |
|
| 2019 | Revenue | 3346 |
|
| 2024 | Revenue | 2500 |
|
| 2025 | Revenue | 5000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | 0% |
|
| 2017 | Year over year | -28.2% |
|
| 2018 | Year over year | -99.9% |
|
| 2019 | Year over year | 14.7% |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-03-31 | Operating margin | Not reported |
|
| 2016-03-31 | Operating margin | Not reported |
|
| 2017-03-31 | Operating margin | Not reported |
|
| 2018 | Operating margin | 6.2% |
|
| 2019 | Operating margin | 22.4% |
|
| 2024 | Operating margin | -12,303.5% |
|
| 2025 | Operating margin | -58,387.3% |
|
| 2015 | Net margin | -10% |
|
| 2016 | Net margin | 1% |
|
| 2017 | Net margin | -22.3% |
|
| 2018 | Net margin | -6,922.5% |
|
| 2019 | Net margin | 9,982.1% |
|
| 2024 | Net margin | -11,928.1% |
|
| 2025 | Net margin | -58,026.4% |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | Not reported | No source recorded |
| 2016 | Operating cash flow | 62000 |
|
| 2017 | Operating cash flow | -203000 |
|
| 2018 | Operating cash flow | 108000 |
|
| 2019 | Operating cash flow | -31000 |
|
| 2024 | Operating cash flow | -258928 |
|
| 2025 | Operating cash flow | -1284615 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable | No source recorded |
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Liabilities / assets | 106% |
|
| 2016 | Liabilities / assets | 103.7% |
|
| 2017 | Liabilities / assets | 124.7% |
|
| 2018 | Liabilities / assets | 117.2% |
|
| 2019 | Liabilities / assets | 104.9% |
|
| 2024 | Liabilities / assets | 1.5% |
|
| 2025 | Liabilities / assets | 14.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Current assets / current liabilities | 0.81× |
|
| 2016 | Current assets / current liabilities | 1.02× |
|
| 2017 | Current assets / current liabilities | 0.52× |
|
| 2018 | Current assets / current liabilities | 0.79× |
|
| 2019 | Current assets / current liabilities | 0.94× |
|
| 2024 | Current assets / current liabilities | 1.89× |
|
| 2025 | Current assets / current liabilities | 0.05× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2015-04-01 – 2016-03-31 | USD 33,000 Exact valueExact value: 33000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 62,000 Exact valueExact value: 62000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-04-01 – 2017-03-31 | −USD 509,000 Exact valueExact value: -509000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 203,000 Exact valueExact value: -203000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-04-01 – 2018-03-31 | −USD 202,000 Exact valueExact value: -202000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 108,000 Exact valueExact value: 108000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-04-01 – 2019-03-31 | USD 334,000 Exact valueExact value: 334000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 31,000 Exact valueExact value: -31000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-04-01 – 2020-03-31 | USD 5.45 million Exact valueExact value: 5452000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.33 million Exact valueExact value: 5333000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-04-01 – 2021-03-31 | −USD 326,000 Exact valueExact value: -326000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 323,000 Exact valueExact value: -323000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-04-01 – 2022-03-31 | −USD 287,171 Exact valueExact value: -287171 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 282,381 Exact valueExact value: -282381 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-04-01 – 2023-03-31 | −USD 8.47 million Exact valueExact value: -8472216 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 368,347 Exact valueExact value: -368347 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-04-01 – 2024-03-31 | −USD 298,202 Exact valueExact value: -298202 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 258,928 Exact valueExact value: -258928 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-04-01 – 2025-03-31 | −USD 2.9 million Exact valueExact value: -2901321 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.28 million Exact valueExact value: -1284615 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
168 filings · 3,287 latest values · 3,287 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001011060, 1011060, NORD, asnb, edgar:1011060
Also known as ADVANSOURCE BIOMATERIALS CORPORATION, AdvanSource Biomaterials Corp, AdvanSource Biomaterials Corporation, Advansource Biomaterials Corp, Advansource Biomaterials Corp., Advansource Biomaterials Corpoartion, Advansource Biomaterials Corporation, CARDIOTECH INTERNATIONAL INC, EKIMAS CORPORATION, EKIMAS Corporation, EKIMAS CORPORATION, EKIMAS Corp, NORDICUS PARTNERS CORPORATION, NORDICUS PARTNERS CORPORATION, Nordicus Partners Corporation, Nordicus Partners Corp, Nordicus Partners Corporation